Most Likely Diagnosis: Recurrent or Progressive Glomerular Disease with Nephrotic Syndrome
The most likely cause is recurrent or progressive glomerular disease (likely related to the childhood nephropathy) manifesting as nephrotic syndrome, which explains both the bilateral pitting edema and the anemia through multiple mechanisms including hemodilution, iron deficiency from urinary losses, and erythropoietin deficiency from worsening renal function.
Clinical Reasoning
Why Nephrotic Syndrome is the Primary Suspect
The combination of warm, bilateral pitting edema extending above the knees in someone with childhood nephropathy strongly suggests nephrotic-range proteinuria. The 1950s hospitalization for "nephropathy" likely represents a primary glomerular disease (possibly minimal change disease, focal segmental glomerulosclerosis, or membranous nephropathy) that may have been in remission for decades but has now recurred or progressed.
Key features supporting this:
- Edema pattern: Bilateral, pitting, and extensive (above knees) indicates severe hypoalbuminemia from urinary protein losses
- Warm edema: Rules out venous thrombosis as primary cause (though thromboembolism remains a complication risk in nephrotic syndrome) 1
- Historical context: Childhood glomerular disease can recur decades later, particularly in adults who had nephrotic syndrome as children
Anemia in This Context
The 30 g/L hemoglobin drop over 2 months has multiple potential contributors in nephrotic syndrome:
- Hemodilution from fluid retention and expanded plasma volume
- Iron deficiency from urinary transferrin losses (common in nephrotic syndrome)
- Erythropoietin deficiency if there is progressive chronic kidney disease
- Urinary erythropoietin losses in heavy proteinuria
Low hemoglobin is closely associated with diabetic nephropathy and other forms of chronic kidney disease 2, and this relationship extends to other glomerular diseases.
Immediate Diagnostic Workup Required
Essential First-Line Tests:
- Urinalysis with microscopy and spot urine protein-to-creatinine ratio or 24-hour urine protein
- Serum albumin (expect <3.0 g/dL if nephrotic syndrome)
- Serum creatinine and eGFR to assess kidney function
- Complete metabolic panel including cholesterol (hyperlipidemia expected) 1
- Iron studies (ferritin, transferrin saturation, serum iron)
- Reticulocyte count to assess bone marrow response
- Peripheral blood smear to exclude hemolysis
Critical Rule-Outs:
Hemolysis must be excluded given the anemia severity. Check:
- LDH, haptoglobin, indirect bilirubin
- Direct antiglobulin test (DAT) - note that initial testing may be falsely negative; monospecific testing for IgM may be needed 3
- Peripheral smear for spherocytes or schistocytes
Hemolysis-associated hemoglobin cast nephropathy can cause both acute kidney injury and anemia 4, 3, but typically presents more acutely and with dark urine, which is not mentioned here. However, autoimmune hemolytic anemia can occur with glomerular disease, so this warrants investigation.
Management Approach
If Nephrotic Syndrome Confirmed:
Anticoagulation consideration: Assess thromboembolism risk versus bleeding risk. Prophylactic anticoagulation should be considered when thromboembolic risk exceeds bleeding risk 1
Hyperlipidemia management: Start statin therapy, particularly given cardiovascular risk factors. Align statin intensity to ASCVD risk based on LDL-C, apolipoprotein B, and other risk enhancers 1
Anemia management:
- Treat iron deficiency if present (intravenous iron may be needed given urinary losses)
- Consider erythropoiesis-stimulating agents if anemia persists despite iron repletion and is related to CKD (ESAs are preferred first-line over HIF-PHIs) 5, 6
- Target hemoglobin individualized to patient but generally avoid transfusion unless symptomatic or hemoglobin critically low
Nephrology referral: Urgent consultation for consideration of kidney biopsy to determine specific glomerular pathology and guide immunosuppressive therapy
If Hemolysis Identified:
Treatment hinges on eliminating the pathogenic driver of intravascular hemolysis 4. For autoimmune hemolytic anemia, corticosteroids are first-line, with rapid cessation of hemolysis typically seen 3.
Common Pitfalls to Avoid
- Don't assume the anemia is solely from "anemia of chronic disease" - investigate all reversible causes including iron deficiency, hemolysis, and nutritional deficiencies
- Don't miss occult hemolysis - initial DAT may be negative; request monospecific testing if clinical suspicion remains 3
- Don't delay anticoagulation assessment - nephrotic syndrome carries significant thromboembolism risk, particularly with albumin <2.5 g/dL 1
- Don't overlook the childhood history - this provides crucial diagnostic context suggesting recurrent glomerular disease rather than new-onset pathology